查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1471139

幹細胞市場：按類型、來源、應用、最終用戶分類 - 2024-2030 年全球預測

Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年幹細胞市場規模為136.6億美元，預計2024年將達到150.5億美元，2030年將達到279.9億美元，複合年成長率為10.79%。

幹細胞市場由用於研究、開發和醫療應用的各種產品和服務組成。這包括銷售幹細胞株、用於操縱和分析幹細胞的設備，以及與幹細胞庫相關的服務以及在各種疾病治療中的應用。幹細胞在再生醫學領域有著廣泛的應用，包括帕金森氏症、阿茲海默症、糖尿病和心臟病。它對於各種癌症治療方法的開發也至關重要。最終用戶包括直接對患者進行幹細胞治療的研究機構、生技公司、製藥公司、醫院和診所。幹細胞市場的成長是由幹細胞研究資金的增加、再生治療需求的增加以及使幹細胞治療更容易獲得和有效的技術進步所推動的。此外，全球慢性病的盛行率不斷上升，需要開發創新的治療方法，並推動對幹細胞領域的進一步投資。然而，胚胎幹細胞研究存在倫理問題，包括幹細胞治療的高成本、需要訓練有素的人員、幹細胞治療的免疫排斥的可能性以及製造幹細胞產品的複雜性，這些都阻礙了胚胎幹細胞研究的發展。治療的普及。同時，幹細胞市場最大的商機在於新藥發現平台的開發、個人化醫療的應用以及幹細胞儲存和分析的技術創新。擴大誘導性多功能幹細胞(iPS 細胞) 的治療應用以及利用幹細胞進行組織和器官再生的 3D 生物列印技術的進步也是值得探索的領域。

主要市場統計
基準年[2023] 136.6億美元
預測年份 [2024] 150.5億美元
預測年份 [2030] 279.9億美元
複合年成長率（%） 10.79%

由於道德和監管障礙較低，成體幹細胞的使用正在增加

成體幹細胞是胚胎發育後存在於全身的未分化細胞。存在於骨髓、血液、腦部和肌肉組織。成體幹細胞是多功能的，可以發展成多種細胞類型，但與多功能能幹細胞相比這是有限的。成體幹細胞主要透過骨髓移植用於治療多種疾病，包括血液疾病。人類胚胎幹細胞 (hESC) 源自於胚囊的內細胞群，囊胚胚胎著床前胚胎的早期階段。這些多功能細胞可以分化成體內的所有細胞類型，提供廣泛的治療可能性。 hESC 具有分化成任何細胞類型的能力，對於了解人類早期發育、遺傳疾病和藥物篩檢具有不可估量的價值。誘導性多功能幹細胞（iPSC）是一種透過引入特定基因從非多功能細胞（通常是成體細胞）合成衍生的幹細胞。 iPSC 在再生醫學領域前景廣闊，因為它們可以在體內生成任何類型的細胞，而不會出現與 hESC 相關的倫理問題。幹細胞市場多種多樣，每種幹細胞都有獨特的優勢，但也面臨不同的挑戰。成體幹細胞廣泛存在，倫理和監管障礙較低，但其分化潛力有限。人類胚胎幹細胞由於其多功能而具有巨大的治療潛力，但倫理爭論和限制性法律阻止其在許多國家的使用。誘導性多功能幹細胞（幹細胞）雖然是一項新技術，可提供量身定做的治療方法並避免倫理限制，但需要進行大量研究以確保臨床應用的安全性和有效性。

擴大幹細胞在發展應用診斷模型的應用

診斷領域是幹細胞應用極為重要的領域，對於各種疾病的早期發現和監測非常有用。幹細胞正在幫助開發模擬人類疾病的診斷模型，使研究人員能夠了解病理學並測試新的診斷方法。對早期準確疾病診斷的需求不斷增加，推動了對涉及幹細胞的創新診斷解決方案的需求。幹細胞在藥物發現和藥物開發中發揮創新作用。提供人類特異性模型有可能透過減少對動物實驗的依賴並提高預測藥物反應的準確性來徹底改變藥物篩檢過程。製藥業降低成本和增加有效藥物管道的壓力正在推動幹細胞技術在藥物發現和藥物開發中的採用。再生醫學是幹細胞最有前景的應用領域，具有治癒受損組織和器官的潛力，並為以前無法治癒的疾病提供解決方案。再生醫學領域正在利用幹細胞的獨特能力來突破傳統醫學的界限。對再生醫學的需求是由患者主導的，通常針對治療選擇有限的情況，例如脊髓損傷、燒燙傷和心臟疾病，因此迫切需要新的治療方法。

區域洞察

在美國，幹細胞市場是由高水準的研究投資和強大的專利環境所推動的。憑藉強大的法規結構，研究機構和公司處於幹細胞研究和臨床試驗的前沿。加拿大消費者越來越了解幹細胞治療的潛在好處，從而推動了需求的成長。然而，該市場的特點是對監管核准和專利申請採取謹慎態度。南美幹細胞市場仍在發展中，但由於醫療基礎設施投資增加和醫療旅遊業興起，預計將出現成長。由於成熟的製藥業和有利的政府政策，歐洲是幹細胞的重要市場。歐盟 (EU) 有關幹細胞研究的嚴格法規確保道德實踐和高品質標準，資金和合作研究機會正在促進市場成長。瑞士、德國、英國和法國等國家對幹細胞研究有著非常支持的氛圍，擁有眾多的跨國合作關係和大量資金。中東地區對幹細胞研究的興趣和投資正在成長，特別是在沙烏地阿拉伯和以色列等以醫療創新而聞名的國家。非洲的幹細胞市場仍在發展但前景廣闊，而南非則處於領先地位。在人口老化加劇、醫療成本上升以及政府支持政策的背景下，亞太地區幹細胞市場正在快速開拓。由於國家主導的措施和對生物技術的大量投資，中國的幹細胞市場正在迅速擴大。日本以其前瞻性的監管政策而聞名，尤其是再生醫學的快速核准制度。日本消費者對幹細胞療法的高度信任很大程度上歸功於政府的廣泛支持和有利於技術進步的文化。印度幹細胞市場正在興起，研究舉措數量不斷增加，消費者興趣不斷成長。

FPNV定位矩陣

FPNV定位矩陣對於評估幹細胞市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對幹細胞市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估及資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 幹細胞市場的市場規模與預測是多少？

2.幹細胞市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3. 幹細胞市場的技術趨勢和法規結構是什麼？

4.幹細胞市場主要廠商的市場佔有率是多少？

5. 進入幹細胞市場的合適型態和策略性手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基於基因組的先進細胞分析技術介紹
      • 增加對幹細胞療法開發的投資
      • 與幹細胞儲存和處理相關的基礎設施開發
    • 抑制因素
      • 幹細胞治療成本高且缺乏熟練的人力資源
    • 機會
      • 擴大 iPSC 的治療應用以及使用幹細胞進行組織和器官再生的 3D 生物列印的進展
      • 擴大幹細胞在個人化醫療的應用
    • 任務
      • 胚胎幹細胞研究的倫理問題
  • 市場區隔分析
    • 類型：由於道德和監管障礙降低，成體幹細胞的使用正在增加
    • 應用：擴大幹細胞在診斷模型開發的應用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章幹細胞市場：依類型

  • 成體幹細胞
  • 人類胚胎幹細胞
  • 誘導多功能能幹細胞

第7章 幹細胞市場：依來源分類

  • 同種異體的
  • 自體移植

第8章幹細胞市場：依應用分類

  • 診斷
  • 藥物發現與開發
  • 再生醫學

第 9 章 幹細胞市場：依最終用戶分類

  • 學術研究所
  • 醫院和細胞庫
  • 製藥和生物技術公司

第10章美洲幹細胞市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區幹細胞市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲幹細胞市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • QHP Capital 收購 Applied StemCell
    • Stem Genomics 與 Pluristyx 合作提供多功能能幹細胞產品和服務
    • denovoMATRIX 推出首款幹細胞產品，擴大產品系列
  • 戰略分析和建議

第14章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-434CCDA04CF2

[187 Pages Report] The Stem Cells Market size was estimated at USD 13.66 billion in 2023 and expected to reach USD 15.05 billion in 2024, at a CAGR 10.79% to reach USD 27.99 billion by 2030.

The stem cell market comprises various products and services used for the research, development, and application of stem cells in medical therapies. It includes the sale of stem cell lines, instruments used in the manipulation and analysis of stem cells, and services related to stem cell banking and therapeutic applications across various disease treatments. Stem cells find extensive applications in regenerative medicine for diseases such as Parkinson's, Alzheimer's, diabetes, and heart disease. They also are vital in developing various cancer treatments. End-users include research institutes, biotech companies, pharmaceutical corporations, hospitals, and clinics applying stem cell therapies directly to patients. Growth in the stem cell market is primarily driven by the increased funding for stem cell research, rising demand for regenerative treatment options, and advancements in technology that make stem cell therapies more accessible and effective. Additionally, the growing incidence rates of chronic diseases worldwide necessitate the development of innovative treatment approaches, fostering further investment in the stem cell sector. However, the adoption of stem cells is hindered by ethical issues covering embryonic stem cell research, the high costs of stem cell therapies, the need for adequately trained personnel, the potential immune rejection of stem cell therapies, and the complexity of manufacturing stem cell products. On the other hand, the most significant opportunities in the stem cell market lie in the development of new drug discovery platforms, applications in personalized medicine, and technological innovations in stem cell preservation and analysis. Expansion of the therapeutic applications of induced pluripotent stem cells (iPSCs) and advancements in 3D bioprinting utilizing stem cells for tissue and organ regeneration are other areas for exploration.

KEY MARKET STATISTICS
Base Year [2023] USD 13.66 billion
Estimated Year [2024] USD 15.05 billion
Forecast Year [2030] USD 27.99 billion
CAGR (%) 10.79%

Type: Increasing usage of adult stem cells due to its fewer ethical and regulatory hurdles

Adult stem cells are undifferentiated cells located throughout the body after embryonic development. They can be discovered in bone marrow, blood, brain, and muscle tissues. Adult stem cells are multipotent, meaning they can develop into more than one cell type but are limited compared to pluripotent stem cells. Adult stem cells are primarily used to treat various diseases, including hematological conditions, through bone marrow transplants. Human embryonic stem cells (hESCs) are sourced from the internal cell group of a blastocyst, an early-stage pre-implantation embryo. These pluripotent cells can develop into any cell type of the body, offering broad therapeutic potential. With their ability to differentiate into any cell type, hESCs are immensely valuable for understanding early human development, genetic diseases, and drug screening. Induced pluripotent stem cells (iPSCs) are a kind of stem cell synthetically derived from non-pluripotent cells, typically adult somatic cells, by introducing certain genes. iPSCs hold promise in regenerative medicine because they can give rise to every cell type in the body without the ethical issues associated with hESCs. iPSCs are particularly promising for personalized medicine, as they can be derived from a patient's cells, reducing the risk of rejection. The stem cell market is diverse, with each type of stem cell offering unique benefits and facing distinct challenges. Adult stem cells are widely used and have fewer ethical and regulatory hurdles but offer limited differentiation potential. Human embryonic stem cells show vast therapeutic potential given their pluripotency, but their use is impaired by considerable ethical debates and restrictive legislation in many countries. Induced pluripotent stem cells, although a newer technology, provide tailored treatments and avoid ethical constraints but require significant research and development to ensure their safety and efficacy in clinical applications.

Application: Expanding the application of stem cells in developing diagnostic models

The diagnostic segment is a crucial area within stem cell applications, facilitating the early detection and monitoring of various diseases. Stem cells are instrumental in developing diagnostic models that mimic human diseases, enabling researchers to understand pathology and test new diagnostic methods. There's a growing need for accurate disease diagnosis early, subsequently increasing the demand for innovative diagnostic solutions involving stem cells. Stem cells play a transformative role in drug discovery and development. They have the potential to revolutionize the drug screening process by providing human-specific models, which can lower the dependency on animal testing and improve the predictive accuracy of drug responses. The pharmaceutical industry's pressure to reduce costs and increase the pipeline of effective drugs is a driving force behind the adoption of stem cell technologies in this drug discovery and development. Regenerative medicine is the most promising application of stem cells, potentially healing damaged tissues and organs and offering solutions for previously untreatable conditions. The regenerative medicine sector is pushing the boundaries of traditional medical treatments, harnessing the unique capabilities of stem cells. The demand in regenerative medicine is patient-driven, often for conditions with limited treatment options, such as spinal cord injuries, burns, and heart diseases, creating a significant need for novel therapeutic approaches.

Regional Insights

In the United States, the stem cell market is driven by high levels of investment in research and a strong patent landscape. With a robust regulatory framework, institutions and companies are at the forefront of stem cell research and clinical trials. Canadian consumers are becoming increasingly knowledgeable about the potential benefits of stem cell therapies, prompting a rise in demand. However, the market is also characterized by a cautious approach to regulatory approvals and patenting. The stem cell market in South America is still in the developmental phase but is expected to grow due to growing investment in healthcare infrastructure and rising medical tourism. Europe is a significant market for stem cells, with the presence of a well-established pharmaceutical industry and favorable government policies. The European Union's strict regulations on stem cell research ensure ethical practices and high-quality standards, while funding and collaboration opportunities contribute to the market growth. Countries such as Switzerland, Germany, the UK, and France showcase a highly collaborative atmosphere for stem cell research, with numerous cross-border partnerships and substantial funding. The Middle East has shown increasing interest in stem cell research and investment, particularly in countries, including Saudi Arabia, or Israel, which is known for its innovation in medical technology. Africa has a nascent but promising stem cell market, with South Africa at the forefront regarding research efforts and regulatory structure. The APAC region is witnessing rapid development in the stem cell market due to the increasing geriatric population, rising healthcare expenditure, and supportive government policies. China's stem cell market is expanding rapidly due to state-led initiatives and significant investment in biotechnology. Japan is known for its forward-looking regulatory policies, especially the fast-track approval system for regenerative medicine. Japanese consumers highly trust stem cell treatments, largely due to extensive government backing and a culture that favors technological advancement. India's stem cell market is emerging, with an increasing number of research initiatives and growing consumer interest.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Stem Cells Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Stem Cells Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Stem Cells Market, highlighting leading vendors and their innovative profiles. These include Advanced Cell Technology, Inc., AlloSource, Inc., Anterogen Co., Ltd., Athersys Inc., Becton, Dickinson and Company, Bioheart Inc., Biorestorative Therapies Inc., BioTime, Inc., BrainStorm Cell Therapeutics Inc., Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell Ltd, GenScript Biotech Corporation, Gilead Sciences, Inc., Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,, JCR Pharmaceuticals Co., Ltd., Lonza Group Ltd, Novartis AG, NuVasive Inc., Pluristyx, Inc., RTI Surgical, Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Adult Stem Cell
    • Human Embryonic Stem Cell
    • Induced Pluripotent Stem Cell
  • Source
    • Allogenic
    • Autologous
  • Application
    • Diagnostics
    • Drug Discovery & Development
    • Regenerative Medicines
      • Cardiology
      • Neurology
      • Oncology
  • End-user
    • Academic & Research Institutes
    • Hospitals & Cell Banks
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Stem Cells Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Stem Cells Market?

3. What are the technology trends and regulatory frameworks in the Stem Cells Market?

4. What is the market share of the leading vendors in the Stem Cells Market?

5. Which modes and strategic moves are suitable for entering the Stem Cells Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Introduction of advanced Genome-based cell analysis techniques
      • 5.1.1.2. Increasing investment in the development of stem cell therapies
      • 5.1.1.3. Infrastructural development related to stem cell banking and processing
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with stem cell therapies and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
      • 5.1.3.2. Growing applications of stem cells in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues surrounding embryonic stem cell research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing usage of adult stem cells due to its fewer ethical and regulatory hurdles
    • 5.2.2. Application: Expanding the application of stem cells in developing diagnostic models
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Adult Stem Cell
  • 6.3. Human Embryonic Stem Cell
  • 6.4. Induced Pluripotent Stem Cell

7. Stem Cells Market, by Source

  • 7.1. Introduction
  • 7.2. Allogenic
  • 7.3. Autologous

8. Stem Cells Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development
  • 8.4. Regenerative Medicines

9. Stem Cells Market, by End-user

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Cell Banks
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Stem Cells Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QHP Capital Acquires Applied StemCell
    • 13.3.2. Stem Genomics, Pluristyx Partner for Pluripotent Stem Cell Products, Services
    • 13.3.3. denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. STEM CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. STEM CELLS MARKET DYNAMICS
  • FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL STEM CELLS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 353. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 363. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 364. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 373. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 374. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 375. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 376. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 377. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 378. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 383. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 384. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 385. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 386. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 387. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 388. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 389. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 390. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICI